ENDV

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/02/2016
Contact Info
  • 6320 Canoga Avenue
  • 15th Floor
  • Woodland Hills, CA 91367

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001528172
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2008
Employees 16 a/o Nov 13, 2012
Company Officers/Contacts
Alan Collier CEO, Interim CFO
Michael Mann President
Don Calabria COO
Steven Barnes VP, Investor Rel.
Leonard Makowka Chief Med. Officer
Company Directors
Alan Collier Chairman
Company Notes
  • Formerly=Hanover Portfolio Acquisitions Inc. until 5-2014
Service Providers
Accounting/Auditing Firm
Rose, Snyder & Jacobs
15821 Ventura Blvd.
Suite 490
Encino, 91436
United States

Legal Counsel
Frank J. Hariton, Esq.
1065 Dobbs Ferry Road
White Plains, NY, 10607
United States

Investor Relations Firm
Not Available
ENDV Security Details
Share Structure
Market Value1 $9,046,728 a/o Dec 02, 2016
Authorized Shares 250,000,000 a/o Nov 28, 2016
Outstanding Shares 129,238,969 a/o Nov 28, 2016
-Restricted 113,166,863 a/o Nov 28, 2016
-Unrestricted 16,072,106 a/o Nov 28, 2016
Held at DTC 15,306,766 a/o Nov 28, 2016
Float 622,092 a/o May 18, 2015
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
ClearTrust, LLC
Shareholders
Shareholders of Record 317 a/o May 17, 2016
Short Selling Data
Short Interest 5,012 (100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security